Abstract:PTBP1 is overexpressed in prostate cancer and is associated with poor prognosis. PTBP1 markedly reinforced genomic DNA stability to desensitize prostate cancer cells to irradiation. Mechanistically, PTBP1 binds to RALY and together regulates alternative splicing of DNMT3B to increase DNMT3B‐L accumulation, leading to hypermethylation of the DUSP2 promoter and downregulation of its expression, and then increasing radioresistance of prostate cancer. Radiotherapy is a curative arsenal for prostate cancer (PCa), but radioresistance seriously compromises its effectiveness. Dysregulated RNA splicing factors are extensively involved in tumor progression. Nonetheless, the role of splicing factors in radioresistance remains largely unexplored in PCa. Here, 23 splicing factors that are differentially expressed between PCa and adjacent normal tissues across multiple public PCa databases are identified. Among those genes, polypyrimidine tract binding protein 1 (PTBP1) is significantly upregulated in PCa and is positively associated with advanced clinicopathological features and poor prognosis. Gain‐ and loss‐of‐function experiments demonstrate that PTBP1 markedly reinforces genomic DNA stability to desensitize PCa cells to irradiation in vitro and in vivo. Mechanistically, PTBP1 interacts with the heterogeneous nuclear ribonucleoproteins (hnRNP) associated with lethal yellow protein homolog (RALY) and regulates exon 5 splicing of DNA methyltransferase 3b (DNMT3B) from DNMT3B‐S to DNMT3B‐L. Furthermore, upregulation of DNMT3B‐L induces promoter methylation of dual‐specificity phosphatase‐2 (DUSP2) and subsequently inhibits DUSP2 expression, thereby increasing radioresistance in PCa. The findings highlight the role of splicing factors in inducing aberrant splicing events in response to radiotherapy and the potential role of PTBP1 and DNMT3B‐L in reversing radioresistance in PCa.

Downregulation of Splicing Factor PTBP1 Curtails FBXO5 Expression to Promote Cellular Senescence in Lung Adenocarcinoma

FBXW7 inactivation induces cellular senescence via accumulation of p53

Cellular Senescence Induced by Down-Regulation of PTBP1 Correlates with Exon Skipping of Mitochondrial-Related Gene NDUFV3

FBXO32-mediated degradation of PTEN promotes lung adenocarcinoma progression

Splicing Factor BUD31 Promotes Ovarian Cancer Progression Through Sustaining the Expression of Anti-Apoptotic BCL2L12

RNA Binding Motif Protein 10 Suppresses Lung Cancer Progression by Controlling Alternative Splicing of Eukaryotic Translation Initiation Factor 4H

Alternative polyadenylation dependent function of splicing factor SRSF3 contributes to cellular senescence.

N6-methyladenosine-modified Circrps6kc1 Regulated Cellular Senescence in Prostate Cancer Via FOXM1/PCNA Axis

Splicing Factor PQBP1 Curtails BAX Expression to Promote Ovarian Cancer Progression

RBM10 Loss Promotes EGFR-Driven Lung Cancer and Confers Sensitivity to Spliceosome Inhibition.

3′ UTR lengthening as a novel mechanism in regulating cellular senescence

PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer

PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2

Suppression of Tumorigenesis in LUAD by LRP1B Through Regulation of the IL-6-JAK-STAT3 Pathway.

Functional Analysis Reveals That RBM10 Mutations Contribute to Lung Adenocarcinoma Pathogenesis by Deregulating Splicing.

PU.1 negatively regulates tumorigenesis in non-small-cell lung cancer

Opposite Expression of HNRNPA2B1 in Cancer and Senescent Cells and Its Regulatory Role in Senescence of Cancer Cells

SRSF1 Modulates PTPMT1 Alternative Splicing to Regulate Lung Cancer Cell Radioresistance

Splicing Factor PTBP1 Silencing Induces Apoptosis of Human Cervical Cancer Cells via PI3K/AKT Pathway and Autophagy

PTBP3 Mediates TGF-β-induced EMT and Metastasis of Lung Adenocarcinoma

Ubiquitin specific peptidase 38 epigenetically regulates KLF transcription factor 5 to augment malignant progression of lung adenocarcinoma